Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center

Journal of Microbiology, Immunology and Infection

Volumn 52, Issue 2, 2019, Pages 304-311

  Huang, Ying Chi ^a   Wu, Ping Feng ^a,b   Lin, Yi Tsung ^a,b   Wang, Fu Der ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Carbapenem resistance; Elizabethkingia meningoseptica; Mortality; Non fermenting Gram negative bacilli

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; COTRIMOXAZOLE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEREMIA; CARBAPENEM RESISTANCE; CENTRAL VENOUS CATHETERIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; COMMUNITY ACQUIRED INFECTION; DISEASE SEVERITY; DRUG EXPOSURE; ELIZABETHKINGIA MENINGOSEPTICA; ELIZABETHKINGIA MENINGOSEPTICA INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE BACTERIUM INFECTION; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NEUTROPENIA; NON-FERMENTING GRAM-NEGATIVE BACTERIUM; OBSERVATIONAL STUDY; PLEURA EFFUSION; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL; ANTIBIOTIC RESISTANCE; CHRYSEOBACTERIUM; DRUG EFFECT; FLAVOBACTERIACEAE INFECTION; GRAM NEGATIVE INFECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOGENICITY; TAIWAN; TERTIARY CARE CENTER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CARBAPENEMS; CHRYSEOBACTERIUM; DRUG RESISTANCE, BACTERIAL; FEMALE; FLAVOBACTERIACEAE INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ODDS RATIO; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; STENOTROPHOMONAS MALTOPHILIA; TAIWAN; TERTIARY CARE CENTERS;

EID: 85051009240     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2018.06.007     Document Type: Article

References (27)

1. Memish, Z.A., Shibl, A.M., Kambal, A.M., Ohaly, Y.A., Ishaq, A., Livermore, D.M., Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia. J Antimicrob Chemother 67 (2012), 1701–1705.
2. Averbuch, D., Avaky, C., Harit, M., Stepensky, P., Fried, I., Ben-Ami, T., et al. Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience. Infection 45 (2017), 327–334.
3. Gniadek, T.J., Carroll, K.C., Simner, P.J., Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle. J Clin Microbiol 54 (2016), 1700–1710.
4. Sievert, D.M., Ricks, P., Edwards, J.R., Schneider, A., Patel, J., Srinivasan, A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 34 (2013), 1–14.
5. Agarwal, S., Kakati, B., Khanduri, S., Gupta, S., Emergence of carbapenem resistant non-fermenting Gram-negative bacilli isolated in an ICU of a tertiary care hospital. J Clin Diagn Res, 11, 2017 Dc04-dc7.
6. Ting, S.W., Lee, C.H., Liu, J.W., Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: a retrospective propensity-matched case control study. J Microbiol Immunol Infect, 2017 Jun 23, 10.1016/j.jmii.2016.08.022.
7. Huang, S.T., Chiang, M.C., Kuo, S.C., Lee, Y.T., Chiang, T.H., Yang, S.P., et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 45 (2015), 356–362.
8. Nutman, A., Glick, R., Temkin, E., Hoshen, M., Edgar, R., Braun, T., et al. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. Clin Microbiol Infect 20 (2014), O1028–O1034.
9. Lee, C.H., Su, T.Y., Ye, J.J., Hsu, P.C., Kuo, A.J., Chia, J.H., et al. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. J Microbiol Immunol Infect 50 (2017), 677–683.
10. Buehrle, D.J., Shields, R.K., Clarke, L.G., Potoski, B.A., Clancy, C.J., Nguyen, M.H., Carbapenem-resistant Pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob Agents Chemother, 61(1), 2017 e01243–16.
11. Chang, Y.T., Lin, C.Y., Chen, Y.H., Hsueh, P.R., Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol, 6, 2015, 893.
12. Wang, C.H., Lin, J.C., Lin, H.A., Chang, F.-Y., Wang, N.-C., Chiu, S.-K., et al. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: a 10-year retrospective study. J Microbiol Immunol Infect 49 (2016), 378–386.
13. Lin, Y.T., Chiu, C.H., Chan, Y.J., Lin, M.L., Yu, K.W., Wang, F.D., et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis 41 (2009), 628–634.
14. Huang, Y.C., Huang, Y.W., Lin, Y.T., Wang, F.D., Chan, Y.J., Yang, T.C., Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan. Eur J Clin Microbiol Infect Dis 36 (2017), 1373–1380.
15. Huang, Y.C., Lin, Y.T., Wang, F.D., Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia. Int J Antimicrob Agents 51 (2018), 47–51.
16. Hsu, M.S., Liao, C.H., Huang, Y.T., Liu, C.Y., Yang, C.J., Kao, K.L., et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur J Clin Microbiol Infect Dis 30 (2011), 1271–1278.
17. Lin, P.Y., Chen, H.L., Huang, C.T., Su, L.H., Chiu, C.H., Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents 36 (2010), 436–440.
18. Jean, S.S., Lee, W.S., Chen, F.L., Ou, T.Y., Hsueh, P.R., Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections. J Hosp Infect 86 (2014), 244–249.
19. Friedman, N.D., Kaye, K.S., Stout, J.E., McGarry, S.A., Trivette, S.L., Briggs, J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002), 791–797.
20. Wu, H.S., Wang, F.D., Tseng, C.P., Wu, T.H., Lin, Y.T., Fung, C.P., Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect 64 (2012), 162–168.
21. Chuang, Y.C., Sheng, W.H., Lauderdale, T.L., Li, S.Y., Wang, J.T., Chen, Y.C., et al. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J Microbiol Immunol Infect 47 (2014), 324–332.
22. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24, 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
23. Ko, H.K., Yu, W.K., Lien, T.C., Wang, J.H., Slutsky, A.S., Zhang, H., et al. Intensive care unit-acquired bacteremia in mechanically ventilated patients: clinical features and outcomes. PLoS One, 8, 2013, e83298.
24. Kaye, K.S., Gales, A.C., Dubourg, G., Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes. Int J Antimicrob Agents 49 (2017), 542–548.
25. Lee, Y.T., Wang, Y.C., Kuo, S.C., Chen, C.T., Liu, C.P., Liu, Y.M., et al. Multicenter study of clinical features of breakthrough Acinetobacter bacteremia during carbapenem therapy. Antimicrob Agents Chemother, 61, 2017 e00931–17.
26. Jeon, Y.D., Jeong, W.Y., Kim, M.H., Jung, I.Y., Ahn, M.Y., Ann, H.W., et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. Medicine (Baltimore), 95, 2016, e4375.
27. Lin, P.Y., Chiu, C.H., Chu, C., Tang, P., Su, L.H., Invasion of murine respiratory tract epithelial cells by Chryseobacterium meningosepticum and identification of genes present specifically in an invasive strain. New Microbiol 29 (2006), 55–62.